دورية أكاديمية
أعرض في EDS

Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021.

التفاصيل البيبلوغرافية
العنوان: Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021.
المؤلفون: Drouin A; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA.; University Medical Center, New Orleans, LA, USA., Plumb ID; Applied Epidemiology Studies Team, Epidemiology Branch, and on detail to the Global Respiratory Viruses Branch Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control, Atlanta, GA, USA., McCullough M; Eagle Health Analytics, Atlanta, GA, USA., James Gist J; Eagle Health Analytics, Atlanta, GA, USA., Liu S; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA., Theberge M; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA., Katz J; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA., Moreida M; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA., Flaherty S; School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA., Chatwani B; School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA., Briggs Hagen M; Applied Epidemiology Studies Team, Epidemiology Branch, and on detail to the Global Respiratory Viruses Branch Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control, Atlanta, GA, USA., Midgley CM; Applied Epidemiology Studies Team, Epidemiology Branch, and on detail to the Global Respiratory Viruses Branch Coronavirus and Other Respiratory Viruses Division, Centers for Disease Control, Atlanta, GA, USA., Fusco D; Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, 70130, USA. dfusco@tulane.edu.; University Medical Center, New Orleans, LA, USA. dfusco@tulane.edu.; School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA. dfusco@tulane.edu.
المصدر: Scientific reports [Sci Rep] 2024 Mar 19; Vol. 14 (1), pp. 6539. Date of Electronic Publication: 2024 Mar 19.
نوع المنشور: Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: COVID-19*/diagnosis , COVID-19*/epidemiology, Humans ; Middle Aged ; Aged ; SARS-CoV-2 ; Cohort Studies ; New Orleans ; Hospitalization
مستخلص: Louisiana experienced high morbidity and mortality from COVID-19. To assess possible explanatory factors, we conducted a cohort study (ClinSeqSer) of patients hospitalized with COVID-19 in New Orleans during August 2020-September 2021. Following enrollment, we reviewed medical charts, and performed SARS-CoV-2 RT-PCR testing on nasal and saliva specimens. We used multivariable logistic regression to assess associations between patient characteristics and severe illness, defined as ≥ 6 L/min oxygen or intubation. Among 456 patients, median age was 56 years, 277 (60.5%) were Black non-Hispanic, 436 (95.2%) had underlying health conditions, and 358 were unvaccinated (92.0% of 389 verified). Overall, 187 patients (40.1%) had severe illness; 60 (13.1%) died during admission. In multivariable models, severe illness was associated with age ≥ 65 years (OR 2.08, 95% CI 1.22-3.56), hospitalization > 5 days after illness onset (OR 1.49, 95% CI 1.01-2.21), and SARS CoV-2 cycle threshold (Ct) result of < 32 in saliva (OR 4.79, 95% CI 1.22-18.77). Among patients who were predominantly Black non-Hispanic, unvaccinated and with underlying health conditions, approximately 1 in 3 patients had severe COVID-19. Older age and delayed time to admission might have contributed to high case-severity. An association between case-severity and low Ct value in saliva warrants further investigation.
(© 2024. The Author(s).)
References: N Engl J Med. 2020 Jun 25;382(26):2534-2543. (PMID: 32459916)
Lancet Infect Dis. 2023 May;23(5):556-567. (PMID: 36681084)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
PLoS One. 2020 Dec 31;15(12):e0244777. (PMID: 33382805)
Clin Microbiol Infect. 2021 Jun;27(6):917.e1-917.e4. (PMID: 33705849)
Clin Infect Dis. 2022 Sep 05;:. (PMID: 36063397)
JAMA. 2021 Oct 12;326(14):1400-1409. (PMID: 34473201)
Nat Med. 2023 Feb;29(2):334-343. (PMID: 36797482)
Ann Intern Med. 2021 Jan;174(1):33-41. (PMID: 32960645)
Nat Rev Microbiol. 2023 Mar;21(3):162-177. (PMID: 36653446)
Int J Epidemiol. 1997 Feb;26(1):224-7. (PMID: 9126524)
N Engl J Med. 2020 Sep 24;383(13):1283-1286. (PMID: 32857487)
JAMA. 2021 Feb 16;325(7):632-644. (PMID: 33475701)
Nat Med. 2022 May;28(5):1031-1041. (PMID: 35361992)
Nat Med. 2021 Jun;27(6):964-980. (PMID: 34002090)
Nat Commun. 2020 Nov 12;11(1):5749. (PMID: 33184277)
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. (PMID: 34710076)
Int J Equity Health. 2022 Jan 14;21(1):6. (PMID: 35031078)
JAMA. 2021 Sep 21;326(11):1065-1067. (PMID: 34387653)
Science. 2022 Mar 11;375(6585):1116-1121. (PMID: 35271324)
Nature. 2020 Aug;584(7821):430-436. (PMID: 32640463)
J Clin Microbiol. 2020 Oct 21;58(11):. (PMID: 32883744)
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115300. (PMID: 33388575)
Clin Infect Dis. 2021 Dec 6;73(11):e4197-e4205. (PMID: 32603425)
Allergy. 2021 Feb;76(2):428-455. (PMID: 33185910)
J Infect. 2020 Sep;81(3):357-371. (PMID: 32615199)
Science. 2022 Mar 11;375(6585):1122-1127. (PMID: 35271343)
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290. (PMID: 34529637)
Lancet Infect Dis. 2020 May;20(5):565-574. (PMID: 32213337)
Infection. 2022 Oct;50(5):1321-1328. (PMID: 35562568)
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550. (PMID: 32379729)
Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579)
J Infect. 2021 Oct;83(4):458-466. (PMID: 34363885)
Nat Rev Microbiol. 2023 Mar;21(3):133-146. (PMID: 36639608)
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1209-1216. (PMID: 33409832)
Nat Med. 2021 May;27(5):892-903. (PMID: 33767405)
معلومات مُعتمدة: U01CK000480 United States CC CDC HHS
فهرسة مساهمة: Keywords: Anti-N antibody; COVID-19; SARS CoV-2; qRT-PCR
تواريخ الأحداث: Date Created: 20240320 Date Completed: 20240321 Latest Revision: 20240323
رمز التحديث: 20240323
مُعرف محوري في PubMed: PMC10951213
DOI: 10.1038/s41598-024-57306-5
PMID: 38503862
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-57306-5